Skip to main content

Table 3 Distribution of prostate cancer T stage before and after PSMA-PET imaging of the prostate

From: Integration of 68Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study

T stage

Initial clinical Staging: n (%)

Relative up-staging by PSMA-PET-imaging: n (%)

Relative down-staging by PSMA-PET-imaging: n (%)

PSMA-PET-imaging staging: n (%)

Biopsy T1c

6 (40.0)

1 (6.7)

1 (6.7)

0

Low risk (≤T2a)

0

0

0

2 (13.3)

Intermediate risk (T2b)

2 (13.3)

1 (6.7)

0

1 (6.7)

High risk (≥T2c)

7 (46.7)

4 (26.7)

1 (6.7)

12 (80.0)